Vascular access device insertion can be difficult and painful. And after insertion, 25% to 50% fail due to infection, blockage, dislodgement or vessel damage. Our goal is to make vascular access complications history. The AVATAR Group undertakes committed scientific work to improve hospital and home care practices, to rigorously and independently test new products, and to promote global networks of vascular access researchers. We strive to eliminate ineffective practices and replace them with innovative solutions, providing patients with a better healthcare experience, and saving global healthcare providers hundreds of millions of dollars.